An interpretable CatBoost model integrating ctDNA methylation markers and clinical features accurately distinguished hepatocellular carcinoma from non-malignant nodules in hepatitis B virus-infected patients.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.